Trials / Terminated
TerminatedNCT01861444
An Observational Study on the Prevalence of Chronic Hepatitis D in Romania and the Efficacy of Treatment With Pegasys (Peginterferon Alfa-2a)
National, Multicenter, Observational Study Evaluating Prevalence, Virological and Clinical Characteristics of Chronic Hepatitis Delta in Romania and Assess Efficacy of Peg-interferon Alfa-2a Treatment in Patients With Chronic Hepatitis D (CHD)
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 45 (actual)
- Sponsor
- Hoffmann-La Roche · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This prospective, multicenter, observational study will assess the prevalence of chronic hepatitis D in patients with chronic hepatitis B in Romania and evaluate the efficacy of Pegasys (peginterferon alfa-2a) in patients with chronic hepatitis D. Eligible patients treated with Pegasys according to current medical practice will be followed until 24 weeks after the end of treatment.
Conditions
Timeline
- Start date
- 2011-03-01
- Primary completion
- 2015-03-01
- Completion
- 2015-03-01
- First posted
- 2013-05-23
- Last updated
- 2016-11-02
Locations
1 site across 1 country: Romania
Source: ClinicalTrials.gov record NCT01861444. Inclusion in this directory is not an endorsement.